Back to top

Image: Bigstock

Top Ranked Momentum Stocks to Buy for March 30th

Read MoreHide Full Article

Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, March 30th:

Virtu Financial, Inc. (VIRT - Free Report) : This provider of market making and liquidity services has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 63.8% over the last 60 days.

Virtu Financial’s shares gained 18.1% over the last one month above the S&P 500’s decrease of 12.8%. The company possesses a Momentum Score of A.

Forty Seven, Inc. : This clinical-stage immuno-oncology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Forty Seven’s shares gained 63% over the last one month. The company possesses a Momentum Score of A.

Moderna, Inc. (MRNA - Free Report) : This clinical stage biotechnology company has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.2% over the last 60 days.

Moderna’s shares gained 16.9% over the last one month. The company possesses a Momentum Score of A.

Novan, Inc. : This clinical development-stage biotechnology company has a Zacks Rank #2 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 34.2% over the last 60 days.

Novan Inc. Price and Consensus

Novan Inc. Price and Consensus

Novan Inc. price-consensus-chart | Novan Inc. Quote

Novan’s shares gained more than 100% over the last one month. The company possesses a Momentum Score of A.

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

The Hottest Tech Mega-Trend of All                

Last year, it generated $24 billion in global revenues. By 2020, it's predicted to blast through the roof to $77.6 billion. Famed investor Mark Cuban says it will produce "the world's first trillionaires," but that should still leave plenty of money for regular investors who make the right trades early.

See Zacks' 3 Best Stocks to Play This Trend >>

 


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Moderna, Inc. (MRNA) - free report >>

Virtu Financial, Inc. (VIRT) - free report >>

Published in